T-cell lymphoma secondary to checkpoint inhibitor therapy.
Anand K, Ensor J, Pingali SR, Hwu P, Duvic M, Chiang S, Miranda R, Zu Y, Iyer S.
Anand K, et al.
J Immunother Cancer. 2020 Feb;8(1):e000104. doi: 10.1136/jitc-2019-000104.
J Immunother Cancer. 2020.
PMID: 32114498
Free PMC article.
Review.